Calliditas Therapeutics AB Overview

Calliditas Therapeutics AB Cost of Revenue

Cost of Revenue analysis for CALT.

Quarterly Cost of Revenue

$53.45M

↑ 276.02% YoY

As of Jun 30, 2024

Annual Cost of Revenue (TTM)

$104.68M

↑ 195.35% YoY

Trailing 12 months ending Jun 30, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin